✦ LIBER ✦

Clinical Trial of Letrozole (femara) versus Aminoglutethimide in Postmenopausal Women with Advanced Breast Cancer

✍ Scribed by Xiaoqing LIU; Santai SONG; Zefei JIANG; Weilian LI; Weixia WANG; Hui YANG

Publisher: Springer
Year: 2005
Tongue: English
Weight: 84 KB
Volume: 4
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-005-0387-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Letrozole and Aminogluteth

Comparison of Letrozole and Aminoglutethimide in Treatment of 113 Cases of Postmenopausal Women with Advanced Breast Cancer

✍ Donggeng Liu; Zhongzhen Guan; Zhenzhou Shen; Qixia Han; Santai Song; Xiaoqing Li 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 85 KB

A randomised trial of tamoxifen versus t

A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer

✍ R. Milsted; T. Habeshaw; S. Kaye; G. Sangster; F. Macbeth; J. Campbell-Ferguson; 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 182 KB

Randomized clinical trial of tamoxifen p

Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer

✍ John H. Glick; Richard H. Creech; Susan Torri; Christopher Holroyde; Harvey Brod 📂 Article 📅 1981 🏛 Springer US 🌐 English ⚖ 914 KB

Summary of aromatase inhibitor clinical

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

✍ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge

Randomized clinical trial of CFP versus

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer

✍ Robert F. Marschke JR.; James N. Ingle; Daniel J. Schaid; James E. Krook; James 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

A randomized trial was performed to determine relative efficacy and toxicity of two first-line combination chemotherapy regimens in women with metastatic breast cancer: CFP (cyclophosphamide, 5-fluorouracil, prednisone) and C M F P (cyclophosphamide, 5-fluorouracil, methotrexate, prednisone). Both r

Use of aromatase inhibitors in postmenop

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer

✍ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast